Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
02/2002
02/21/2002CA2419073A1 Novel alicyclic imidazoles as h3 agents
02/20/2002EP1180028A1 Il-8 receptor antagonists
02/20/2002EP1180025A1 Il-8 receptor antagonists
02/20/2002EP0841922B1 1h-4(5)-substituted imidazole derivatives
02/20/2002CN1336930A Bridged heterocyclic derivatives
02/19/2002USRE37555 Process and composition for multicomponent one hundred percent solid fabric softeners
02/19/2002US6348482 Catechols as antimicrobial agents
02/14/2002WO2002012243A2 SYNTHESIS OF (R)-3-(4-BROMOBENZYL)-1-(3,5-DICHLOROPHENYL)-5-IODO-3-METHYL-1-H-IMIDAZO[1,2-a]IMIDAZOL-2-ONE
02/14/2002WO2002012224A2 Bicyclic compounds as h3 receptor ligands
02/14/2002WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/14/2002WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/14/2002WO2002012166A2 Triamine derivative melanocortin receptor ligands and methods of using same
02/14/2002WO2001062739A3 Thioimidazolidine derivatives as light stabilizers for polymers
02/14/2002WO2001053270A3 Process for producing n-halogenated organic compounds
02/14/2002WO2001049668A3 4-aryl-1-difluoromethoxyimidazoles and use thereof as herbicides
02/14/2002WO2001042173A3 Method for the preparation of enantiomerically enriched compounds
02/14/2002US20020019563 A S-(2-(1-iminoethyl)amino)ethyl)-2-methyl-L-cysteine
02/14/2002US20020019539 Antiarthritc agents; anticancer agent
02/14/2002US20020019527 Antitumor, antcarcinogenic agents
02/14/2002US20020019429 Antiarthritic agents; osteoporosis
02/14/2002US20020019428 For agriculture
02/14/2002US20020019416 Esters and amides as pla2 inhibitors
02/14/2002US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
02/14/2002US20020019390 Imidazole and imidazoline derivatives and uses thereof
02/14/2002DE10035991A1 Nagellackzusammensetzung Nail polish composition
02/14/2002CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/14/2002CA2419027A1 Bicyclic compounds as h3 receptor ligands
02/14/2002CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/14/2002CA2416906A1 Synthesis of (r)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo[1,2-a]imidazol-2-one
02/13/2002EP1179599A2 Method for producing lysine derivative
02/13/2002EP1178987A1 Substituted benzoylisoxazoles and the use thereof as herbicides
02/13/2002EP1178969A1 Gastrin and cholecystokinin receptor ligands
02/13/2002EP1178963A1 Ion channel modulating agents
02/13/2002EP1178958A2 N-cyanomethyl amides as protease inhibitors
02/13/2002EP1178954A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
02/13/2002EP1178796A1 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
02/13/2002CN1335837A Imidazole compounds and medicinal use thereof
02/13/2002CN1079095C Process for producing D.L-methionine or salt thereof
02/12/2002US6346624 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
02/12/2002US6346620 Methods for preparation of 2-(4-(4-(4,5-dichloro-2-methylimidazol-1-yl)butyl)-1-piperazinyl)-5-fluoropyrimidine and salts thereof
02/12/2002US6346532 Antidiabetic, antilipemic, and hypoglycemic agents; adrenergic stimulants
02/12/2002US6346527 Guanidine derivatives
02/12/2002CA2053705C Piperazine derivatives
02/07/2002WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/07/2002WO2002010141A1 Imidazole derivatives
02/07/2002WO2002010140A2 Imidazolyl derivatives
02/07/2002WO2002010096A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
02/07/2002WO2002009703A1 Method for treating cryptorchidism
02/07/2002WO2002009686A2 Cdc25 phosphatase inhibitors
02/07/2002WO2002009648A2 Antimicrobial biaryl compounds
02/07/2002WO2001074792A3 Process for the preparation of matrix metalloproteinase inhibitors
02/07/2002US20020016473 Enantioselectivity of alpha,beta-unsaturated aldehydes
02/07/2002US20020016471 Inhibitors of p38
02/07/2002US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists
02/07/2002US20020016366 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
02/07/2002US20020016339 Anticoagulants
02/07/2002US20020015884 Ionic liquids II
02/07/2002US20020015883 Ionic liquids
02/07/2002DE10037149A1 Substituierte Arylketone Substituted aryl ketones
02/07/2002CA2418121A1 Antimicrobial biaryl compounds
02/07/2002CA2418115A1 Imidazole derivatives
02/07/2002CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/07/2002CA2417262A1 Cdc25 phosphatase inhibitors
02/07/2002CA2417204A1 Imidazolyl derivatives
02/07/2002CA2416303A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
02/06/2002EP1178010A1 Colorless aqueous ammonium sulfide solution
02/06/2002EP1177254A1 Antistatic agents and resin compositions incorporated therein
02/06/2002EP1177199A1 Ionic liquids and production and use thereof
02/06/2002EP1176958A1 Novel catechols as antimicrobial agents
02/06/2002EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
02/06/2002EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists
02/06/2002EP0882024B1 Retroviral protease inhibiting compounds
02/06/2002CN1334808A Benzamide derivs. and their use as APOB-100 secretion inhibitors
02/06/2002CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists
02/06/2002CN1334798A Phenylglycine derivatives
02/06/2002CN1334797A 3,4-diamino-3-cyclobutene-1,2-dione derivs. which inhibit leukocyte adhesion mediated by VLA-4
02/06/2002CN1078889C Non-pepitde tachykinin receptor antagonists
02/05/2002US6344565 Preparation of cycloacid
02/05/2002US6344564 Fungicidal 2-imidazolin-5-ones and 2-imidazoline-5-thiones
02/05/2002US6344563 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
02/05/2002US6344484 Treatment of tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, and rheumatoid arthritis
02/05/2002US6344473 Imidazoles useful as nitric oxide synthase inhibitors
02/05/2002US6344439 Agents for promoting bone formation
01/2002
01/31/2002WO2002008834A1 Radiation sensitive compositions containing image quality and profile enhancement additives
01/31/2002WO2002008213A1 Colchinol derivatives as angiogenesis inhibitors
01/31/2002WO2002008210A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
01/31/2002WO2002008199A2 Efficient ligand-mediated ullmann coupling of anilines and azoles
01/31/2002WO2002008198A2 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus
01/31/2002WO2002008191A1 Potassium channel inhibitors
01/31/2002WO2002008189A1 Compounds and inhibitors of phospholipases
01/31/2002WO2002008183A2 Potassium channel inhibitors
01/31/2002WO2002007725A1 Method for treating fibrotic diseases or other indications ic
01/31/2002WO2002007683A1 Antimicotic nail varnish composition
01/31/2002WO2001070682A3 Carbocyclic side chain containing metalloprotease inhibitors
01/31/2002WO2000034261A3 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
01/31/2002US20020013475 Catalyst for unsaturated carbonyl compounds
01/31/2002US20020013356 New polycyclic indanylimidazoles with alpha2 adrenergic activity
01/31/2002US20020013319 For therapy of tumor or restenosis
01/31/2002US20020013281 11,12-Dideoxy-3-de((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L -ribohexopyranosyl)oxy) 6-0-methyl 3-oxo-12,11-(oxycarbonyl) ((4-(4-(4-aminophenyl)-1H-imidazol-1-yl)-butyl)imino))-erythromycin; grampositive bacteria, esp. staphyloccus
01/31/2002DE10035144A1 Cyclische Aminosäurederivate Cyclic amino acid derivatives